AGP Executive Report
Last update: 3 hours agoCancer & Drug Development: NIH says its Human Cancer Models Initiative now includes 665 patient-derived lab models covering 25 tumor types from 2,780 donors, aiming to speed precision therapy research. Public Health & Food Allergy: Boston Children’s “poop pills” trial reports early signals that oral fecal microbiome capsules can boost peanut tolerance in some adults with severe allergy. Obesity Science: A Yale study links semaglutide’s long-term weight loss to activation of hypothalamus hunger-linked AgRP neurons, challenging the idea that GLP-1 drugs only work by suppressing appetite. Infectious Disease Lab Capacity: UT Health San Antonio’s fungus testing lab describes identifying dozens of new fungal species and tackling rising drug resistance. Neuro & Dementia Support: University of Worcester research finds food-centered activities can help people with dementia feel connected, leading to new practical resources for community groups. AI & Research Tools: Jisc expands university research commercialisation support via Dimensions Industry Partnerships to map and benchmark industry links. Space Science: China’s Shenzhou-23 crew prepares for long-duration spaceflight experiments on brain, bones, and wellbeing. Environment & Climate: A study on turbulent wind shows how it reshapes odor signals animals use for navigation, with potential uses in search-and-rescue and leak detection.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
